Tag : Dasotraline


FDA Says No to Dasotraline for ADHD

The agency requests additional efficacy and tolerability data for the investigational dual-acting dopamine and norepinephrine reuptake inhibitor for treatment of attention-deficit/hyperactivity disorder (ADHD). Medscape Medical...

This website uses cookies to improve your experience. We'll assume you're ok with this, but you can opt-out if you wish. Accept Read More

Privacy & Cookies Policy